56. Reoperation and loco-regional chemotherapy improve survival in glioblastoma patients

A. Silvani, A. Pozzi, A. Salmaggi, A. Franzini, A. Boiardi

Research output: Contribution to journalArticle

Abstract

We scheduled a protocol by combining both local bleomycin and mitoxantrone in addition to systemic chemotherapy in 54 primary GBM selected pts. According to our eligibility requirements. Moreover 15 pts underwent a second surgery. l) BCNU 100 mg/m 2 + CDDP 90 mg/m 2 I.V. for 5 times 2) bleomycin 0,75 mg in 2 cc of physiological solution days 1-2-3 and mitoxantrone 3 mg day 4 trough Ommaya every 20 days. 3) At recurrence all patients received PVC every 6 weeks. Drugs interstitially delivered by-pass the blood-brain-barrier and can achieve higher and more prolonged concentrations into the tumor area. There was no evidence of increased brain toxicity from the local delivery of bleomycin and mitoxantrone. The whole group of pts. (54), those treated with locoregional chemotherapy (25) and 15 pts reoperated on had 23.1; 26,5 and 27,6 mos ST respectively. Our present findings emphasize the safety and effectiveness of loco- regional chemotherapy as noted in the literature. Extensive surgery could be justifiable if it is a part of the whole program of treatment. We feel confident that the addition of intratumoral chemotherapy was effective and was a determining factor in association with a second tumor resection in the prolongation of ST in our selected patients.

Original languageEnglish
Pages (from-to)257-258
Number of pages2
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Glioblastoma
Reoperation
Mitoxantrone
Bleomycin
Drug Therapy
Survival
Carmustine
Blood-Brain Barrier
Polyvinyl Chloride
Neoplasms
Safety
Recurrence
Brain
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

56. Reoperation and loco-regional chemotherapy improve survival in glioblastoma patients. / Silvani, A.; Pozzi, A.; Salmaggi, A.; Franzini, A.; Boiardi, A.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 257-258.

Research output: Contribution to journalArticle

@article{47b1763d0b3a4519aed4a4778a89d89a,
title = "56. Reoperation and loco-regional chemotherapy improve survival in glioblastoma patients",
abstract = "We scheduled a protocol by combining both local bleomycin and mitoxantrone in addition to systemic chemotherapy in 54 primary GBM selected pts. According to our eligibility requirements. Moreover 15 pts underwent a second surgery. l) BCNU 100 mg/m 2 + CDDP 90 mg/m 2 I.V. for 5 times 2) bleomycin 0,75 mg in 2 cc of physiological solution days 1-2-3 and mitoxantrone 3 mg day 4 trough Ommaya every 20 days. 3) At recurrence all patients received PVC every 6 weeks. Drugs interstitially delivered by-pass the blood-brain-barrier and can achieve higher and more prolonged concentrations into the tumor area. There was no evidence of increased brain toxicity from the local delivery of bleomycin and mitoxantrone. The whole group of pts. (54), those treated with locoregional chemotherapy (25) and 15 pts reoperated on had 23.1; 26,5 and 27,6 mos ST respectively. Our present findings emphasize the safety and effectiveness of loco- regional chemotherapy as noted in the literature. Extensive surgery could be justifiable if it is a part of the whole program of treatment. We feel confident that the addition of intratumoral chemotherapy was effective and was a determining factor in association with a second tumor resection in the prolongation of ST in our selected patients.",
author = "A. Silvani and A. Pozzi and A. Salmaggi and A. Franzini and A. Boiardi",
year = "1997",
language = "English",
volume = "18",
pages = "257--258",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - 56. Reoperation and loco-regional chemotherapy improve survival in glioblastoma patients

AU - Silvani, A.

AU - Pozzi, A.

AU - Salmaggi, A.

AU - Franzini, A.

AU - Boiardi, A.

PY - 1997

Y1 - 1997

N2 - We scheduled a protocol by combining both local bleomycin and mitoxantrone in addition to systemic chemotherapy in 54 primary GBM selected pts. According to our eligibility requirements. Moreover 15 pts underwent a second surgery. l) BCNU 100 mg/m 2 + CDDP 90 mg/m 2 I.V. for 5 times 2) bleomycin 0,75 mg in 2 cc of physiological solution days 1-2-3 and mitoxantrone 3 mg day 4 trough Ommaya every 20 days. 3) At recurrence all patients received PVC every 6 weeks. Drugs interstitially delivered by-pass the blood-brain-barrier and can achieve higher and more prolonged concentrations into the tumor area. There was no evidence of increased brain toxicity from the local delivery of bleomycin and mitoxantrone. The whole group of pts. (54), those treated with locoregional chemotherapy (25) and 15 pts reoperated on had 23.1; 26,5 and 27,6 mos ST respectively. Our present findings emphasize the safety and effectiveness of loco- regional chemotherapy as noted in the literature. Extensive surgery could be justifiable if it is a part of the whole program of treatment. We feel confident that the addition of intratumoral chemotherapy was effective and was a determining factor in association with a second tumor resection in the prolongation of ST in our selected patients.

AB - We scheduled a protocol by combining both local bleomycin and mitoxantrone in addition to systemic chemotherapy in 54 primary GBM selected pts. According to our eligibility requirements. Moreover 15 pts underwent a second surgery. l) BCNU 100 mg/m 2 + CDDP 90 mg/m 2 I.V. for 5 times 2) bleomycin 0,75 mg in 2 cc of physiological solution days 1-2-3 and mitoxantrone 3 mg day 4 trough Ommaya every 20 days. 3) At recurrence all patients received PVC every 6 weeks. Drugs interstitially delivered by-pass the blood-brain-barrier and can achieve higher and more prolonged concentrations into the tumor area. There was no evidence of increased brain toxicity from the local delivery of bleomycin and mitoxantrone. The whole group of pts. (54), those treated with locoregional chemotherapy (25) and 15 pts reoperated on had 23.1; 26,5 and 27,6 mos ST respectively. Our present findings emphasize the safety and effectiveness of loco- regional chemotherapy as noted in the literature. Extensive surgery could be justifiable if it is a part of the whole program of treatment. We feel confident that the addition of intratumoral chemotherapy was effective and was a determining factor in association with a second tumor resection in the prolongation of ST in our selected patients.

UR - http://www.scopus.com/inward/record.url?scp=33746363547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746363547&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746363547

VL - 18

SP - 257

EP - 258

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -